Elicio Therapeutics ELTX
NASDAQ ELTX
$1.94 +0.27 (+16.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Cash from Financing Activities (2020 - 2026)

Updated

Elicio Therapeutics (ELTX) reported Cash from Financing Activities of $16.51 million for Q2 2026, up 38.4% from $11.93 million a year earlier and up 105.7% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Elicio Therapeutics' Cash from Financing Activities came in at $38.97 million, down 26.8% year-over-year; for FY2025, it came in at $36.7 million, down 13.3% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $42.32 million in FY2024 (+9.6%), $38.61 million in FY2023 (+82.1%), $21.2 million in FY2022 (-80.2%) and $107.17 million in FY2021 (+104.5%).
  • The Q2 2026 figure ranks as the highest quarterly Cash from Financing Activities since Q3 2024.
  • Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 31.2%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q4 2021 (growth of 100.0%); the low point was Q3 2023 (a decline of 99.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $8.03 million (Q1 2026), $4.86 million (Q4 2025) and $9.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -8.53 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -5.05 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -3.89 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 2.34 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -3.66 Bn
10 Elicio Therapeutics 42.49 Mn -35.13 Mn - 16.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.51 Mn
Mar 31, 2026 8.03 Mn
Dec 31, 2025 4.86 Mn
Sep 30, 2025 9.57 Mn
Jun 30, 2025 11.93 Mn
Mar 31, 2025 10.33 Mn
Dec 31, 2024 227,000.00
Sep 30, 2024 30.75 Mn
Jun 30, 2024 316,000.00
Mar 31, 2024 11.02 Mn
Dec 31, 2023 7.00 Mn
Sep 30, 2023 60,000.00
Jun 30, 2023 21.51 Mn
Mar 31, 2023 10.04 Mn
Dec 31, 2022 11.18 Mn
Sep 30, 2022 8.78 Mn
Jun 30, 2022 1.26 Mn
Mar 31, 2022 -14,000.00
Dec 31, 2021 404,000.00
Sep 30, 2021 699,000.00
API Access

Elicio Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ELTX&period=max&api_key=YOUR_API_KEY